Purchase Order 12561519P0020
Award Date 12/17/18
Potential Completion Date 12/26/18
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, received a contract award on March 20, 2018, through a Blanket Purchase Agreement (BPA) call with a civilian federal agency's Southeast Area office. The contract, valued at $8,256.23 with a firm fixed price structure, covers the procurement of Nextera XT DNA Library Preparation Kit, Index Kit, High Output Kit, and PhiX Control Kit—specialized reagent kits essential for...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genomic sequencing and analysis technologies, was awarded a Purchase Order contract by the Office of Administrative Services Procurement Management Branch on April 7, 2015, with a ceiling value of $29,529.80 and an ultimate completion date of April 30, 2016. This Firm Fixed Price contract, which carries no set-aside designation, is to be performed in Athens, Georgia. As a leading provider of DNA and RNA sequencing...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a Blanket Purchase Agreement (BPA) call valued at $49,428.29 for reagents for sequencing under a civilian federal agency's Northeast Area division. The contract, issued on September 30, 2016, with an ultimate completion date of October 29, 2019, utilized a firm fixed-price structure with no set-aside designation. This award reflects Illumina's specialized...
- Illumina, Inc. was awarded a BPA (Blanket Purchase Agreement) call contract on December 17, 2014, by a civilian federal agency within the Plains Area, with an ultimate completion date of September 9, 2019. Under this firm fixed-price contract valued at $14,241.01, Illumina supplied sequencing reagent kits including two units of MiSeq Reagent Kit V3 (600 cycle) and three units of NextSeq500 High Output Kit (300 cycles). The contract carried no set-aside designation, reflecting Illumina's...
- This is a federal contract award to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, by the Office of Administrative Services Procurement Management Branch of the U.S. government. The contract, valued at $213,646.31, is for the delivery of ILLUMINA SUPPLIES, including various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and consumables. The contract is a firm fixed price Blanket Purchase Agreement (BPA) call, with no set-aside...
- Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a BPA call contract on August 10, 2015, by a civilian federal agency (Northeast Area) for the procurement of sequencing consumables. The contract, valued at $3,013.92 under a firm fixed price arrangement, covers two MiSeq Reagent Kit V2 (500 Cycle) units and one Nextera Index Kit (96 indexes, 384 samples). The work was performed in San Diego, California, with an ultimate...
- This is a firm fixed-price purchase order awarded by a civilian federal agency to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The $47,945.52 contract is for kitted reagents to prepare DNA sequencing libraries and complete four instrument runs using Illumina's HiSeq2000 DNA sequencer, generating 200 base pairs of sequence data per molecule. The award is not associated with a set-aside designation or a larger federal contract vehicle. Illumina has been awarded...
- This firm fixed-price delivery order, valued at $23,021.54, was awarded to Illumina, Inc. by the Northeast Area of a civilian federal agency. The order is for the purchase of sequencing supplies, including reagents and consumables, to support the agency's use of Illumina's NextSeq 2000 sequencing platform for bacterial isolate and metagenome sequencing. The order has an ultimate completion date of October 13, 2024. Illumina has a history of providing sequencing instruments, reagents, and...
- Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a $24,814.61 call under a Blanket Purchase Agreement (BPA AG-32SC-B-14-0005) by a civilian federal agency's Southeast Area office on February 9, 2016. The contract, which operated on a firm fixed-price basis with no set-aside designation, was for the delivery of HiSeq Rapid SBS Kit V2 (200 cycles) sequencing reagents. The work was performed at Illumina's San...
- Illumina, Inc. was awarded a delivery order valued at $17,333.02 by a civilian Northeast Area federal agency on August 9, 2021, with an ultimate completion date of September 9, 2021. This contract utilizes a firm fixed-price structure and does not employ a set-aside designation. The delivery order, referencing BPA priced items from quote number 4367642 submitted by Sam Hester, procures NextSeq 500/550 Kit V2.5 for 150 cycles (catalog number 20024907) at a quantity of four units at $2,954 each...